UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Pericoronary adipose tissue computed tomography attenuation distinguishes different stages of coronary artery disease: a cross-sectional study

European heart journal cardiovascular imaging, 2021-02, Vol.22 (3), p.298-306

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery Disease

Clinical chemistry (Baltimore, Md.), 2011-01, Vol.57 (1), p.33-39

2011

Link zum Volltext

Verfügbarkeit prüfen

Using genetics to guide treatment and drug development in cardiovascular medicine: time to reveal the proof in the pudding

Cardiovascular research, 2020-02, Vol.116 (2), p.e30-e32

Nicholls, Stephen J

2020

Link zum Volltext

Verfügbarkeit prüfen

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

European heart journal, 2023-07, Vol.44 (25), p.2292-2304

2023

Link zum Volltext

Verfügbarkeit prüfen

Strengthening cardiovascular trials across Australia and New Zealand-the Alliance for Cardiovascular Trials (ANZACT) Network

European heart journal, 2022-05, Vol.43 (17), p.1612-1614

2022

Link zum Volltext

Verfügbarkeit prüfen

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

European heart journal, 2023-05, Vol.44 (18), p.1594-1607

2023

Link zum Volltext

Verfügbarkeit prüfen

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

European heart journal, 2014-04, Vol.35 (15), p.960-968

2014

Link zum Volltext

Verfügbarkeit prüfen

Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease

European journal of preventive cardiology, 2020-07, Vol.27 (10), p.1091-1100

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis

European heart journal, 2021-12, Vol.43 (1), p.32-40

2021

Link zum Volltext

Verfügbarkeit prüfen

Redox biomarkers in cardiovascular medicine

European heart journal, 2015-07, Vol.36 (25), p.1576-1582

2015

Link zum Volltext

Verfügbarkeit prüfen

Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis

European heart journal, 2022-09, Vol.43 (34), p.3243-3254

2022

Link zum Volltext

Verfügbarkeit prüfen

Combining cholesterol-lowering strategies with imaging data: a visible benefit?

European journal of preventive cardiology, 2019-03, Vol.26 (4), p.365-379

2019

Link zum Volltext

Verfügbarkeit prüfen

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy

European heart journal, 2013-11, Vol.34 (41), p.3182-3190

2013

Link zum Volltext

Verfügbarkeit prüfen

Taking the lid off the pot on marijuana and cardiovascular disease

European journal of preventive cardiology, 2017-11, Vol.24 (17), p.1831-1832

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN

European heart journal cardiovascular imaging, 2014-04, Vol.15 (4), p.380-388

2014

Link zum Volltext

Verfügbarkeit prüfen

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER

European heart journal. Cardiovascular pharmacotherapy, 2016-10, Vol.2 (4), p.212-217

2016

Link zum Volltext

Verfügbarkeit prüfen

Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis

European journal of preventive cardiology, 2016-05, Vol.23 (7), p.744-747

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of coronary ischaemia in women: Are we any closer to deciphering the code?

European journal of preventive cardiology, 2018-05, Vol.25 (7), p.717-718

2018

Link zum Volltext

Verfügbarkeit prüfen

Examining adherence to activity monitoring devices to improve physical activity in adults with cardiovascular disease: A systematic review

European Journal of Preventive Cardiology, 2019-03, Vol.26 (4), p.382-397

2019

Link zum Volltext

Verfügbarkeit prüfen

Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events

European heart journal, 2020-08, Vol.41 (31), p.2965-2973

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors underlying regression of coronary atheroma with potent statin therapy

European heart journal, 2013-06, Vol.34 (24), p.1818-1825

2013

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction

European journal of preventive cardiology, 2017-03, Vol.24 (4), p.373-381

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(8)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Pericoronary adipose tissue computed tomography attenuation distinguishes different stages of coronary artery disease: a cross-sectional study

Plasma Myeloperoxidase Predicts Incident Cardiovascular Risks in Stable Patients Undergoing Medical Management for Coronary Artery Disease

Using genetics to guide treatment and drug development in cardiovascular medicine: time to reveal the proof in the pudding

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes

Strengthening cardiovascular trials across Australia and New Zealand-the Alliance for Cardiovascular Trials (ANZACT) Network

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011

Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease

Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis

Redox biomarkers in cardiovascular medicine

Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis

Combining cholesterol-lowering strategies with imaging data: a visible benefit?

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy

Taking the lid off the pot on marijuana and cardiovascular disease

Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER

Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis

Mechanisms of coronary ischaemia in women: Are we any closer to deciphering the code?

Examining adherence to activity monitoring devices to improve physical activity in adults with cardiovascular disease: A systematic review

Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular events

Factors underlying regression of coronary atheroma with potent statin therapy

Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction

Aktive Filter

Suchergebnisse filtern